Skip navigation

Shelli R. Kesler, PhD

Dr. Kesler is a neuropsychologist and cognitive neuroscientist at Stanford University School of Medicine. She is the Director of the Neuropsychology and Cognitive Neuroscience Lab (NCNL). She is a faculty member of the Center for Interdisciplinary Brain Sciences Research as well as the Center on Stress and Health. She also is a Member of the Stanford Cancer Institute and Bio-X Program.

Dr. Kesler is interested in the application of cognitive neuroscience to the study of non-CNS conditions. Specifically, her research program focuses on the neurotoxic effects of cancer chemotherapy, often referred to as “chemobrain”. She has helped advance this field of research by demonstrating that chemotherapy is associated with a pattern of subtle but diffuse brain injury. She has also introduced a novel, home-based cognitive enhancement program for individuals who are struggling with cognitive difficulties. She was a 2008 recipient of the NIH Director’s New Innovator Award for her research in cognition and cancer.

Dr. Kesler’s research methods combine advanced neuroimaging techniques, computational neuroscience and cognitive-behavioral psychometrics. She is particularly interested in how large-scale brain networks are differentially organized during health and disease. She also emphasizes the use of machine learning in the development of diagnostic and prognostic neuroimaging biomarkers.

Dr. Kesler is unique in that her research and clinical practice involves both children and adults. This allows her to investigate important lifespan issues related to cognitive neuroscience such as altered neurodevelopment and brain aging. She has authored multiple scientific publications as well as the book “Improving Cognitive Function After Cancer”.



Shelli R Kesler